Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2023 16:01 ET | Source: Inari Medical, Inc.

Inari Medical to Announce First Quarter 2023 Financial Results

IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
March 06, 2023 08:00 ET | Source: Inari Medical, Inc.

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from...
February 27, 2023 16:01 ET | Source: Inari Medical, Inc.

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
February 07, 2023 16:01 ET | Source: Inari Medical, Inc.

Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
January 31, 2023 16:01 ET | Source: Inari Medical, Inc.

Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

IRVINE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
January 12, 2023 08:00 ET | Source: Inari Medical, Inc.

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

IRVINE, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from...
January 10, 2023 08:00 ET | Source: Inari Medical, Inc.

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
December 21, 2022 16:01 ET | Source: Inari Medical, Inc.

Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
November 03, 2022 16:01 ET | Source: Inari Medical, Inc.

Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

IRVINE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
November 02, 2022 16:05 ET | Source: Inari Medical, Inc.

Inari Medical Reports Third Quarter 2022 Financial Results

IRVINE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...